Enanta Pharmaceuticals Inc. buy Westpark Capital
Start price
30.09.25
/
50%
€10.60
Target price
30.09.26
€23.89
Performance (%)
10.38%
Price
06.02.26
€10.70
Summary
This prediction is currently active. The prediction currently has a performance of 10.38%. This prediction currently runs until 30.09.26. The prediction end date can be changed by Westpark_Capital at any time. Westpark_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Enanta Pharmaceuticals Inc. | -0.926% | -0.926% |
| iShares Core DAX® | 1,93 % | -2,11 % |
| iShares Nasdaq 100 | -0,18 % | -5,90 % |
| iShares Nikkei 225® | 7,08 % | 6,46 % |
| iShares S&P 500 | -0,20 % | -3,67 % |
Comments by Westpark_Capital for this prediction
In the thread Enanta Pharmaceuticals Inc. diskutieren
Enanta Pharmaceuticals (NASDAQ:ENTA) had its price target raised by analysts at Westpark Capital from $24.00 to $28.00. They now have a "buy" rating on the stock.
Ratings data for ENTA provided by MarketBeat
Stopped prediction by Westpark_Capital for Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.60
02.09.25
02.09.25
€20.51
02.09.26
02.09.26
40.79%
06.02.26
06.02.26
